Exousia Bio (LMMY) Operating Expenses (2022 - 2025)

Exousia Bio has disclosed Operating Expenses across 4 years of filings, most recently posting $174897.0 for Q4 2025.

• Operating Expenses for Q4 2025 came in at $174897.0, up 2405.33% year-over-year; the trailing twelve-month figure through Nov 2025 was $226787.0 (up 863.41% YoY), and the FY2025 annual result was $31843.0, up 13.42% from the prior year.
• Operating Expenses came in at $174897.0 for Q4 2025 at Exousia Bio, up from $31814.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $174897.0 in Q4 2025 to a low of -$3751.0 in Q2 2025.
• The 4-year median for Operating Expenses is $8551.0 (2022), against an average of $23311.2.
• Peak annual rise in Operating Expenses reached 2405.33% in 2025, while the deepest fall reached 1545.18% in 2025.
• Exousia Bio's Operating Expenses stood at $8407.0 in 2022, then slipped by 11.41% to $7448.0 in 2023, then retreated by 6.27% to $6981.0 in 2024, then jumped by 2405.33% to $174897.0 in 2025.
• The last three Operating Expenses figures came in at $174897.0 (Q4 2025), $31814.0 (Q3 2025), and -$3751.0 (Q2 2025), per Business Quant data.